<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ding F</submitter><funding>Simon Foundation</funding><funding>Lundbeck Foundations</funding><funding>Novo Nordisk</funding><funding>NCCIH NIH HHS</funding><funding>NIA NIH HHS</funding><funding>Adelson Medical Research Foundation</funding><funding>NHLBI NIH HHS</funding><funding>CNS2, Inc</funding><funding>NINDS NIH HHS</funding><funding>National Institutes of Health</funding><funding>U.S. Army Research Office</funding><funding>NIH HHS</funding><pagination>1726-1739</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11068329</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>147(5)</volume><pubmed_abstract>Progressive neuronal loss is a hallmark feature distinguishing neurodegenerative diseases from normal ageing. However, the underlying mechanisms remain unknown. Extracellular K+ homeostasis is a potential mediator of neuronal injury as K+ elevations increase excitatory activity. The dysregulation of extracellular K+ and potassium channel expressions during neurodegeneration could contribute to this distinction. Here we measured the cortical extracellular K+ concentration ([K+]e) in awake wild-type mice as well as murine models of neurodegeneration using K+-sensitive microelectrodes. Unexpectedly, aged wild-type mice exhibited significantly lower cortical [K+]e than young mice. In contrast, cortical [K+]e was consistently elevated in Alzheimer's disease (APP/PS1), amyotrophic lateral sclero</pubmed_abstract><journal>Brain : a journal of neurology</journal><pubmed_title>Dysregulation of extracellular potassium distinguishes healthy ageing from neurodegeneration.</pubmed_title><pmcid>PMC11068329</pmcid><funding_grant_id>R01AT012312</funding_grant_id><funding_grant_id>R01 NS110776</funding_grant_id><funding_grant_id>R01 AT011439</funding_grant_id><funding_grant_id>MURI W911NF1910280</funding_grant_id><funding_grant_id>R01AT011439</funding_grant_id><funding_grant_id>U19 NS128613</funding_grant_id><funding_grant_id>R01 AG072298</funding_grant_id><funding_grant_id>R01 AT012312</funding_grant_id><funding_grant_id>R01 HL122578</funding_grant_id><funding_grant_id>R01HL122578</funding_grant_id><pubmed_authors>Ding F</pubmed_authors><pubmed_authors>Weikop P</pubmed_authors><pubmed_authors>Rasmussen RN</pubmed_authors><pubmed_authors>Sun Q</pubmed_authors><pubmed_authors>Goldman SA</pubmed_authors><pubmed_authors>Peng S</pubmed_authors><pubmed_authors>Xu Q</pubmed_authors><pubmed_authors>Kang N</pubmed_authors><pubmed_authors>Nedergaard M</pubmed_authors><pubmed_authors>Song W</pubmed_authors><pubmed_authors>Long C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dysregulation of extracellular potassium distinguishes healthy ageing from neurodegeneration.</name><description>Progressive neuronal loss is a hallmark feature distinguishing neurodegenerative diseases from normal ageing. However, the underlying mechanisms remain unknown. Extracellular K+ homeostasis is a potential mediator of neuronal injury as K+ elevations increase excitatory activity. The dysregulation of extracellular K+ and potassium channel expressions during neurodegeneration could contribute to this distinction. Here we measured the cortical extracellular K+ concentration ([K+]e) in awake wild-type mice as well as murine models of neurodegeneration using K+-sensitive microelectrodes. Unexpectedly, aged wild-type mice exhibited significantly lower cortical [K+]e than young mice. In contrast, cortical [K+]e was consistently elevated in Alzheimer's disease (APP/PS1), amyotrophic lateral sclero</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-04-30T03:20:06.59Z</modification><creation>2025-04-05T23:52:10.627Z</creation></dates><accession>S-EPMC11068329</accession><cross_references><pubmed>38462589</pubmed><doi>10.1093/brain/awae075</doi></cross_references></HashMap>